EXCLUSIVE: Filmmaker Eric Aronson spent 22 years in Hollywood as a screenwriter before moving back to his native Boston and ...

While several infra projects suffered on account of pandemic, even after two years of normalcy, revamp of Bandra’s K B Bhabha ...

UConn announced Thursday that it raised about $720 million from lead donors during the “quiet phase” of the campaign, which began in 2020. The $1.5 billion ... state-of-the-art nursing ...

--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069 ... with lung cancer worldwide each year ...

Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes. Vertex Pharmaceuticals is conducting the pivotal phase 3 portion of a phase 1/2/3 ...

Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June 2025 Two parallel Phase 2b trials in AD and asthma planned to start in 4Q25 and 1Q26, respectively ...

Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the primary goal of significantly reducing A1C levels compared to placebo at ...

Westside residents, community partners and elected officials gathered at the site of the now-demolished YFD building to break ground on the first phase of housing. Construction is slated to begin ...

Eli Lil­ly re­port­ed the first Phase 3 da­ta for its oral GLP-1 or­for­glipron Thurs­day morn­ing, say­ing the drug suc­ceed­ed in a type 2 di­a­betes tri­al … ...

Orforglipron cut A1C by 1.2–1.5% and reduced weight up to 15.8 lbs in adults with type 2 diabetes. Over 65% of high-dose patients reached an A1C of 6.5% or less after 40 weeks of treatment.

The topline results are from ACHIEVE-1, the first phase III trial of an oral GLP-1 drug to successfully reach completion, a press release notes. Taken as a once-daily pill, orforglipron, unlike oral ...

CHICAGO, IL / ACCESS Newswire / April 16, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome a leading ...